J. Virchow

发表

Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper

B. Yawn, W. Busse, H. Schünemann, 2010 .

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA 2 LEN paper

Bateman, B. Yawn, W. Busse, 2010 .

Inhaler devices for asthma: a call for action in a neglected field

J. Haughney, S. Palkonen, J. Virchow, 2011, European Respiratory Journal.

Inhaled Corticosteroid/Long-Acting β2-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe

J. Bousquet, J. Haughney, D. Costa, 2011, International Archives of Allergy and Immunology.

Persistence with asthma treatment is low in Germany especially for controller medication – a population based study of 483 051 patients

J. Virchow, J. Virchow, J. Hasford, 2010, Allergy.

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

C. Kropf-Sanchen, H. Kauczor, H. Watz, 2022, Scientific reports.

Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflammation

J. Virchow, C. Klein, M. Lommatzsch, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

C. Kropf-Sanchen, H. Kauczor, H. Watz, 2022, Scientific reports.

IgE und Anti-IgE bei Asthma: eine wechselvolle Geschichte

J. Virchow, M. Lommatzsch, K. Bergmann, 2017, Pneumologie.

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.

J. Virchow, 2002, Chest.

Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER

J. Virchow, A. Papi, G. Georges, 2022, Clinical and translational allergy.

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

B. Yawn, W. Busse, H. Schünemann, 2010, Allergy.

Normalization of Airflow Obstruction with Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies

J. Virchow, A. Papi, W. Canonica, 2021 .

Persistent Airflow Limitation and the Risk for Moderate-Severe Asthma Exacerbations: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies

J. Virchow, A. Papi, D. Singh, 2021 .

Use of Montelukast in tapering inhaled corticosteroid therapy: an open-label, 48-week trial

D. Price, J. Virchow, R. Olivenstein, 2001 .

Present role of sublingual immunotherapy in allergic diseases

C. Bachert, J. Virchow, K. Bergmann, 2007 .

P227 Efficacy And Safety Of Budesonide–formoterol (bf) Spiromax® In Adults And Adolescents With Asthma: Randomised Comparison With Bf Turbuhaler®

J. Virchow, R. Rodríguez-Roisín, G. Gopalan, 2014, Thorax.

Vitamin D binding protein and vitamin D in human allergen‐induced endobronchial inflammation

J. Virchow, M. Lommatzsch, P. Julius, 2014, Clinical and experimental immunology.

P229 Once-daily Tiotropium Respimat® As Add-on To At Least Medium- To High-dose Ics, With Or Without Laba, Improves Lung Function In Patients With Symptomatic Asthma, Independent Of Allergic Status

J. Virchow, T. Casale, R. Dahl, 2014, Thorax.

Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status

R. Dahl, J. Virchow, E. Pizzichini, 2014, Allergy, Asthma & Clinical Immunology.

The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation

F. Di Virgilio, M. Idzko, D. Ferrari, 2010, Allergy.

Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood

W. Luttmann, J. Virchow, K. Bratke, 2005, European journal of immunology.

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort

C. Kropf-Sanchen, H. Watz, J. Virchow, 2019, Respiratory Research.

R. Holle, C. Kropf-Sanchen, H. Watz, 2020, BMC Pulmonary Medicine.

Chronic cough in Germany: results from a general-population survey

J. Virchow, C. Jannowitz, V. Li, 2021, ERJ Open Research.

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET

H. Kauczor, H. Watz, J. Virchow, 2020, Scientific Reports.

A survey of the burden of allergic rhinitis in Europe

J. Bousquet, G. Scadding, J. Virchow, 2007 .

Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients – an observational, cross sectional study in four countries in Europe

P. Demoly, J. Mullol, J. Virchow, 2011, Journal of medical economics.

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.

J. Virchow, V. Backer, P. Kuna, 2016, JAMA.

Comparable responses of immunological markers in Japanese and European subjects after SQ HDM SLIT-tablet treatment.

J. Virchow, T. Stranzl, H. Mosbech, 2019, Allergology international : official journal of the Japanese Society of Allergology.

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma

J. Virchow, R. Rodríguez-Roisín, A. Papi, 2016, BMC Pulmonary Medicine.

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline

I. Pavord, J. Virchow, J. Virchow, 2020, Allergy.

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.

V. Backer, P. Kuna, J. Virchow, 2016, JAMA.